Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10048171HBVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30004651HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30004652HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30002798HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30007200HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30007201HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30007202HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30075419HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30075420HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30075421HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TCGA Plot Options
Drug Information
GenePRKCA
DrugBank IDDB06641
Drug NamePerifosine
Target IDBE0001132
UniProt IDP17252
Regulation Type
PubMed IDs16528479
CitationsKnowling M, Blackstein M, Tozer R, Bramwell V, Dancey J, Dore N, Matthews S, Eisenhauer E: A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trial. Invest New Drugs. 2006 Sep;24(5):435-9.
GroupsInvestigational
Direct ClassificationDialkyl phosphates
SMILESCCCCCCCCCCCCCCCCCCOP([O-])(=O)OC1CC[N+](C)(C)CC1
Pathways
PharmGKB
ChEMBLCHEMBL372764